In an opinion piece in the British Medical Journal, researchers propose incorporating local knowledge as a strategy for adapting to extreme events and food insecurity.

PrECOG, LLC, today announced the publication of final results from the pivotal phase 3 PATINA study in the New England Journal of Medicine which evaluated whether adding palbociclib to anti-HER2 and endocrine therapy, following induction chemotherapy, could delay disease progression in patients with hormone receptor–positive (HR+), human epidermal growth factor receptor 2–positive (HER2+) metastatic breast cancer. Results showed a median progression-free survival (PFS) of 44.3 months in the palbociclib arm, compared with 29.1 months in the control arm.

A Chinese Journal of Natural Medicines review outlines how AI can help clarify the molecular mechanisms of traditional Chinese medicine formulas, from pharmacokinetics prediction to target and synergy discovery.

Continuous monitoring of biomarkers is essential for early disease detection, treatment evaluation, and personalized health management, yet most clinical tests rely on invasive, single-point blood sampling. 

With an increasing use of ultrasonography-based diagnosis, there is a need to develop affordable alternatives to conventional ultrasound gel, ensuring patient comfort. A team of researchers from Japan has recently developed a reusable, solid ultrasound gel pad composed of tamarind seed gum. This gel pad demonstrated improved patient satisfaction compared to conventional gel, eliminating discomfort such as stickiness or tickling, while showing no degradation in image quality.